Reuters - Health Report

Click to View in Browser

Tuesday, October 17, 2017

Japan's "Blade Library" offers joy of blade running to amputees

TOKYO (Reuters) - Haruta Saito, a young Japanese amputee who dreams of becoming a Paralympian, remembers strapping on a prosthetic "running blade" for the first time.

Regeneron-Sanofi drug succeeds mid-stage study

(Reuters) - Regeneron Pharmaceuticals Inc and Sanofi SA said on Monday their drug to treat inflammation in the esophagus, mainly caused by food allergies, met the main goal of a mid-stage study.

Chi-Med, AstraZeneca lung cancer drug shrinks resistant tumors

LONDON (Reuters) - An experimental cancer drug discovered by Hutchison China MediTech has demonstrated promising activity in shrinking tumors in lung cancer patients whose disease had worsened following treatment with approved medicines.

Trump says he could jettison drug czar pick

WASHINGTON (Reuters) - U.S. President Donald Trump said on Monday he would review a report that his nominee for drug czar championed a law that weakened the government's ability to fight the nation's opioid epidemic, and said he could consider jettisoning the pick.

Aimmune teams with Regeneron, Sanofi on peanut allergy drug

(Reuters) - Aimmune Therapeutics Inc said on Monday it would collaborate with Regeneron Pharmaceuticals Inc and Sanofi to develop its experimental peanut allergy drug.

More men than women infected with oral human papillomavirus

(Reuters Health) - Roughly one in nine U.S. men have oral infections of the cancer-causing human papillomavirus (HPV), more than triple the infection rate for women, a new study suggests.

BrainStorm enrolls first patients in advanced ALS stem cell trial

TEL AVIV (Reuters) - BrainStorm Cell Therapeutics said the first patients have been enrolled in a late-stage trial of its treatment for amyotrophic lateral sclerosis (ALS) at Massachusetts General Hospital and UC Irvine Medical Center in California.

Some mothers may not seek early help for kids with developmental delays

(Reuters Health) - When mothers trust their friends and neighbors more than doctors or struggle to access or afford care, they may be less likely to seek out medical help for young kids with developmental delays, a small U.S. study suggests.

Intensive resistance training safe, effective for women with osteoporosis

(Reuters Health) - High-intensity resistance and impact training (HiRIT) may improve bone and muscle strength in select postmenopausal women with osteoporosis, according to a small study in Australia.

U.S. judge in Texas invalidates Allergan patents on Restasis

(Reuters) - A U.S. judge on Monday invalidated patents on Allergan Plc's dry-eye medicine Restasis on grounds that the patents cover ideas that are obvious, sending shares of the pharmaceutical company down 3.5 percent.